| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Change Management > Managing Change - Information Overload |
|
Just Other Articles - Managing Change - Information Overload
"There are many things a wise man might wish to be ignorant." Ralph Waldow Emerson said that over a century ago and man was he prophetic. We are According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product bombarded with information today and we don't do a very good job of sorting out what is meaningful and what isn't. We get reports, voice mails ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in and of course an inbox full of emails, all giving the appearance of being urgent and important. When managing change you better be a master of s lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. orting incoming information. When you embarked on the change journey you had an objective, right? If you didn’t you're screwed anyway so let's here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ork off the assumption that you did. Let's say you know what problem you are trying to solve and you have agreement on what success will look li d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ke when you do. With that knowledge you're ready to make some decisions along the way. The really big question is when the information bombards ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc you can you do anything with it? Does it have an impact on your project? When I run change projects people come out of the woodwork wanting to easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi 'share' information. They have more reasons to send you this stuff than Bush has for the way the war in Iraq is going. Some folks will fill your nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically inbox with trivia, pure nonsense, just to get noticed. When you're managing a change project you must be disciplined about the information you and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ allow to take up your time. If you don’t ... you'll pay the price of the tyranny of information to flows over you like an avalanche and has you ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi holed up in your office at midnight trying to 'answer' emails. You must look at the information coming in, whether it be a new report, a person ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a who wants to 'share', or any number of other forms information that shows up disguised as the one thing you've been waiting for, Don't let it h dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ppen to you. Ask yourself if the information relevant, important or actionable in relation to your projects end state. Be ruthless. If it isn’t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin one of these three, then don't burn a brain cell on it. If you're tough about it, it will force people to rediscover a long and unused skill, t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen alking to one another. They just might have to converse with you instead of sending you off a hundred emails to convince you how important they t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel are. I did an experiment one time when I was Vice President of Worldwide Logistics at Compaq. At the time, this was about 1996, I was coming in ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust each morning to an inbox of two to three hundred emails, everyday. I told my Assistant to begin deleting half of them every morning. We made a g y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ame out of it. One morning I'd have her delete the top half, the next morning the bottom half, then every other one, it was fun. You know what? . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de In three months, not one person called. Nothing happened. I had no clue what was in half of those emails and nothing changed. You'll find at lea elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip st half of all information you're receiving is pure, unadulterated BS. To manage change means to manage change. Let nothing take your time away tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:4 Steps to Successful Interviewing
|